Literature DB >> 6735033

Interaction between quercetin and Ca2+-calmodulin complex: possible mechanism for anti-tumor-promoting action of the flavonoid.

H Nishino, E Naito, A Iwashima, K Tanaka, T Matsuura, H Fujiki, T Sugimura.   

Abstract

Quercetin was found to have similar inhibitory effects on tumor promoter-induced phenomena to those of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist. Moreover, quercetin was shown to interact directly with the Ca2+-calmodulin complex. These results suggest that quercetin may act as a calmodulin antagonist, and that its antagonistic effect on calmodulin may be important in its anti-tumor-promoting action in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6735033

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  5 in total

1.  The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C.

Authors:  E Middleton; P Ferriola; G Drzewiecki; R D Sofia
Journal:  Agents Actions       Date:  1989-08

2.  Effect of flavonoids on tumor promoter-induced basophil histamine release and protein kinase C.

Authors:  E Middleton; P Ferriola; G Drzewiecki
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

3.  Effects of quercetin on single Ca(2+) release channel behavior of skeletal muscle.

Authors:  Eun Hui Lee; Gerhard Meissner; Do Han Kim
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

Review 4.  Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.

Authors:  P J O'Dwyer; D Shoemaker; D S Zaharko; C Grieshaber; J Plowman; T Corbett; F Valeriote; S A King; J Cradock; D F Hoth
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.

Authors:  G Scambia; F O Ranelletti; P B Panici; M Piantelli; G Bonanno; R De Vincenzo; G Ferrandina; C Rumi; L M Larocca; S Mancuso
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.